deepali kumar

A randomised clinical trial in Canada has found that three doses of the Moderna vaccine are effective at boosting organ transplant recipients’ immune response to the coronavirus, suggesting they would be better protected from illness and infection. The finding could result in the expedited approval of third jabs for this vulnerable population.